www.fool.com Open in urlscan Pro
104.18.24.135  Public Scan

URL: https://www.fool.com/investing/2023/04/25/medtronic-partnering-with-nvidia-is-it-a-buy/
Submission: On April 26 via manual from GB — Scanned from GB

Form analysis 0 forms found in the DOM

Text Content

Skip to main contentEnable accessibility for visually impairedOpen the
accessibility menu Open the Accessible Navigation Menu







Search
Log In Help Join The Motley Fool
Our Services
Investing Basics angle-down
Premium Services
Stock Advisor
Our Flagship Service
Return
395%
S&P Return
118%
Rule Breakers
High-growth Stocks
Return
208%
S&P Return
100%
Returns as of 04/26/2023
View Our Services
Investing 101
 * How to Invest Money
 * What to Invest In
 * How to Invest in Stocks
 * How to Invest in Index Funds
 * How to Invest in ETFs
 * How to Invest in Real Estate
 * Financial Dictionary

Best Accounts
 * Best Stock Brokers
 * Best Brokers for Beginners
 * Best IRA Accounts
 * Best Roth IRA Accounts
 * Best Options Brokers
 * Best Crypto Apps

Stock Market Basics
 * Stock Market 101
 * Types of Stocks
 * Stock Market Sectors
 * Stock Market Indexes
 * S&P 500
 * Dow Jones
 * Nasdaq Composite

Stock Market angle-down
Premium Services
Stock Advisor
Our Flagship Service
Return
395%
S&P Return
118%
Rule Breakers
High-growth Stocks
Return
208%
S&P Return
100%
Returns as of 04/26/2023
View Our Services
Stocks
 * Growth Stocks
 * Value Stocks
 * Dividend Stocks
 * Small Cap Stocks
 * Large Cap Stocks
 * Blue Chip Stocks
 * How to Buy Stocks

Industries to Invest In
 * Consumer Goods
 * Technology
 * Energy
 * Healthcare
 * Financial
 * Cryptocurrency
 * NFTs

News
 * Top Stocks to Buy in 2023
 * Stock Market News

Retirement angle-down
Getting Started
 * Retirement 101
 * Why to Start Saving Now
 * Types of Retirement Accounts
 * 401k Basics
 * IRA Basics
 * HSA Basics

Planning for Retirement
 * How Much Do I Need to Retire?
 * When To Retire
 * Factoring in Social Security
 * What is the Full Retirement Age?
 * Investing for Retirement
 * Retirement Strategies

Retired: What Now?
 * Retiring in 2023
 * Withdrawal Strategies
 * Healthcare in Retirement
 * Taxes in Retirement
 * Estate Planning

Personal Finance angle-down
Credit Cards
 * Best Credit Cards
 * Best Cash Back Cards
 * Best Balance Transfer Cards
 * Best Travel Credit Cards
 * Best 0% Credit Cards
 * Best Rewards Cards
 * Best Cards for Bad Credit

Bank & Loans
 * Best Savings Accounts
 * Best Checking Accounts
 * Best CD Rates
 * Best Personal Loans
 * Best Debt Consolidation Loans

Homebuying
 * Best Mortgage Lenders
 * Best Mortgage Refi Lenders
 * Best Lenders for First-time Buyers
 * Best FHA Mortgage Lenders
 * Current Mortgage Rates

Guides
 * Credit Cards 101
 * Bank Accounts 101
 * Home Loans 101
 * Pay Off Debt
 * Increase Your Credit Score

About Us angle-down
Our Purpose:
To make the world smarter, happier, and richer.

Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps
millions of people attain financial freedom through our website, podcasts,
books, newspaper column, radio show, and premium investing services.

Who Is the Motley Fool?
 * About Us
 * Investing Philosophy
 * Reviews
 * The Motley Fool Foundation
 * Newsroom
 * Contact Us
 * Publishing Standards

Fool Podcasts
 * Podcasts Home
 * Motley Fool Money
 * Rule Breaker Investing

Social Media
 * Facebook
 * Twitter
 * YouTube
 * Discussion Boards
 * CAPS - Stock Picking Community

Other Services
 * The Ascent

Latest Stock Picks
Bars Times


Search
 * Our Services
 * Investing Basics
   angle-down angle-up
   Investing 101
    * How to Invest Money
    * What to Invest In
    * How to Invest in Stocks
    * How to Invest in Index Funds
    * How to Invest in ETFs
    * How to Invest in Real Estate
    * Financial Dictionary
   
   Best Accounts
    * Best Stock Brokers
    * Best Brokers for Beginners
    * Best IRA Accounts
    * Best Roth IRA Accounts
    * Best Options Brokers
    * Best Crypto Apps
   
   Stock Market Basics
    * Stock Market 101
    * Types of Stocks
    * Stock Market Sectors
    * Stock Market Indexes
    * S&P 500
    * Dow Jones
    * Nasdaq Composite
   
   Premium Services
   Stock Advisor
   Our Flagship Service
   Return
   395%
   S&P Return
   118%
   Rule Breakers
   High-growth Stocks
   Return
   208%
   S&P Return
   100%
   Returns as of 04/26/2023
   View Our Services
 * Stock Market
   angle-down angle-up
   Stocks
    * Growth Stocks
    * Value Stocks
    * Dividend Stocks
    * Small Cap Stocks
    * Large Cap Stocks
    * Blue Chip Stocks
    * How to Buy Stocks
   
   Industries to Invest In
    * Consumer Goods
    * Technology
    * Energy
    * Healthcare
    * Financial
    * Cryptocurrency
    * NFTs
   
   News
    * Top Stocks to Buy in 2023
    * Stock Market News
   
   Premium Services
   Stock Advisor
   Our Flagship Service
   Return
   395%
   S&P Return
   118%
   Rule Breakers
   High-growth Stocks
   Return
   208%
   S&P Return
   100%
   Returns as of 04/26/2023
   View Our Services
 * Retirement
   angle-down angle-up
   Getting Started
    * Retirement 101
    * Why to Start Saving Now
    * Types of Retirement Accounts
    * 401k Basics
    * IRA Basics
    * HSA Basics
   
   Planning for Retirement
    * How Much Do I Need to Retire?
    * When To Retire
    * Factoring in Social Security
    * What is the Full Retirement Age?
    * Investing for Retirement
    * Retirement Strategies
   
   Retired: What Now?
    * Retiring in 2023
    * Withdrawal Strategies
    * Healthcare in Retirement
    * Taxes in Retirement
    * Estate Planning
 * Personal Finance
   angle-down angle-up
   Credit Cards
    * Best Credit Cards
    * Best Cash Back Cards
    * Best Balance Transfer Cards
    * Best Travel Credit Cards
    * Best 0% Credit Cards
    * Best Rewards Cards
    * Best Cards for Bad Credit
   
   Bank & Loans
    * Best Savings Accounts
    * Best Checking Accounts
    * Best CD Rates
    * Best Personal Loans
    * Best Debt Consolidation Loans
   
   Homebuying
    * Best Mortgage Lenders
    * Best Mortgage Refi Lenders
    * Best Lenders for First-time Buyers
    * Best FHA Mortgage Lenders
    * Current Mortgage Rates
   
   Guides
    * Credit Cards 101
    * Bank Accounts 101
    * Home Loans 101
    * Pay Off Debt
    * Increase Your Credit Score
 * About Us
   angle-down angle-up
   Who Is the Motley Fool?
    * About Us
    * Investing Philosophy
    * Reviews
    * The Motley Fool Foundation
    * Newsroom
    * Contact Us
    * Publishing Standards
   
   Fool Podcasts
    * Podcasts Home
    * Motley Fool Money
    * Rule Breaker Investing
   
   Social Media
    * Facebook
    * Twitter
    * YouTube
    * Discussion Boards
    * CAPS - Stock Picking Community
   
   Other Services
    * The Ascent
   
   Our Purpose:
   To make the world smarter, happier, and richer.
   
   Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps
   millions of people attain financial freedom through our website, podcasts,
   books, newspaper column, radio show, and premium investing services.
 * Log In
 * Help
 * Join The Motley Fool

Latest Stock Picks
Free Article
Join Our Premium Members And Get More In-Depth Stock Guidance and Research


MEDTRONIC IS PARTNERING WITH NVIDIA TO CREATE POTENTIALLY GAME-CHANGING TECH. IS
THE STOCK A BUY?

By Adria Cimino – Apr 25, 2023 at 1:14PM


KEY POINTS

 * Medtronic will use Nvidia AI technology to detect precancerous tissue earlier
   -- and improve patient outcomes.
 * The medical device giant sees AI as the key to personalized medicine.
 * 10 stocks we like better than Medtronic Plc


NYSE: MDT


MEDTRONIC PLC



Market Cap


Today's Change
Arrow-Thin-Down
(%) 
Current Price
$89.69
Price as of April 25, 2023, 3:00 p.m. ET

You’re reading a free article with opinions that may differ from The Motley
Fool’s Premium Investing Services. Become a Motley Fool member today to get
instant access to our top analyst recommendations, in-depth research, investing
resources, and more. Learn More


MEDTRONIC MAY BE AMONG THE COMPANIES TO DOMINATE THE AI HEALTHCARE MARKET.

Medtronic (MDT) is not new to innovation. The medical device giant sells a broad
range of cutting-edge products, such as the Hugo robotic surgery system and the
world's first insulin pump featuring meal detection technology to regulate
insulin levels. Medtronic's products are used worldwide to address more than 70
health problems.

This portfolio has brought the device maker billions of dollars in revenue and
profit. But the company's growth may not have reached its maximum. In fact, one
particular thing might spur a new wave of growth at Medtronic. The company
recently partnered with Nvidia on an artificial intelligence (AI) project -- and
it could be a game changer for doctors, patients, and the company. Does this
make Medtronic stock a buy? Let's find out.


MEDTRONIC AND AI

First, a little background on Medtronic and AI. Medtronic has been exploring and
using AI for some time. In fact, its work in the area is already bearing fruit.

For example, it's the only company that has scored U.S. Food and Drug
Administration (FDA) clearance for spine surgery predictive models. Last year,
the company won regulatory clearance for its UNiD spine analyzer 4.0 platform --
a massive surgical database that powers algorithms to help surgeons better
predict eventual spinal alignment. AI allows surgeons to visualize the most
likely outcomes for a particular patient, and that helps them better plan their
procedures.

AI "is the key to unlocking a new level of personalized medicine in the 21st
century," Bob White, executive vice president of Medtronic's medical surgical
portfolio, is quoted as saying on the company's website.



The company has even defined a "AI compass," a list of guiding principles for
the company to use when applying AI to healthcare. So it's fair to say Medtronic
is going all-in on AI.

Let's move on to the latest news. Medtronic is already using its AI tool GI
Genius to detect polyps that may lead to colorectal cancer. Now Medtronic is
planning to integrate Nvidia Holoscan and Nvidia IGX to further help doctors
identify precancerous tissue using "AI-enhanced" diagnostic images.

The partnership also aims to create a broad platform of AI that can
progressively improve diagnostics and result in better outcomes. The idea is
that third-party developers will be able to create AI tools that may be
distributed through GI Genius. A third partner, Cosmo Pharmaceuticals, is
running an innovation center website, allowing developers to build and test
potential AI software that may one day become part of the GI Genius platform.

This is exciting because Medtronic may benefit from its own technology and that
of Nvidia -- and because outside talent may eventually contribute to GI Genius.



"The possibility for GI Genius to host multiple real-time AI applications is a
game changer," said Giovanni Di Napoli, president of Medtronic's
gastrointestinal business, in a press release.

Arrows-In Collapse



NYSE: MDT

Medtronic Plc
Today's Change
(%) $0.00
Current Price
$89.69
Arrow-Thin-Down
YTD1w1m3m6m1y 5y
+10.33%
Price VS S&P
MDT


KEY DATA POINTS

Market Cap

Day's Range
$89.43 - $91.00
52wk Range
$75.77 - $108.25
Volume
3,910
Avg Vol

Gross Margin
0.00%
Dividend Yield
N/A


A GROWING AI HEALTHCARE MARKET

It's also important to keep in mind that the global market for AI in healthcare
is forecast to expand at a compound annual growth rate of more than 37% from
next year through 2030, according to Grand View Research. Those who establish
themselves as leaders have a lot to gain.

Medtronic is among the top five medical device companies worldwide poised to
dominate in the AI healthcare world, according to research company GlobalData.
Still, competition may be tough. That top five includes other heavyweights, like
Johnson & Johnson, which spent almost $15 billion on research and development
(R&D) last year.

We don't have full-year results for Medtronic yet, but in the first nine months
of the fiscal year, the company spent about $2 billion on R&D. So J&J has the
resources to take the lead, but that won't necessarily weigh on Medtronic as
more than one player may benefit from an AI revolution.




EARNINGS AND GROWTH

Does this AI deal with Nvidia make Medtronic a buy? The efforts in AI are a big
plus, but I wouldn't buy Medtronic for its AI efforts only. I would consider the
company's general earnings picture and growth prospects as well.

And in these areas, you'll find more reasons to like Medtronic. The company has
increased earnings over time.



MDT Net Income (Annual) data by YCharts

Today it's streamlining its portfolio by spinning off its patient monitoring and
respiratory interventions businesses. It's completed acquisitions that should
boost growth -- like that of Affera, which strengthens its cardiac ablation
portfolio. And over the past year, Medtronic has won more than 150 product
approvals in major geographies. Medtronic also puts a focus on R&D investment,
targeting growth at or above revenue growth.

So what do investors have to pay for all of this?



MDT PE Ratio data by YCharts

Medtronic trades for 29 times trailing-12-month earnings. That's around its
lowest levels over the past decade. This looks dirt cheap. That's because
Medtronic's focus on AI -- and its new products and efforts right now -- should
lead to solid long-term growth. That makes this top healthcare stock a buy
today, one that could deliver big over time.


SHOULD YOU INVEST $1,000 IN MEDTRONIC PLC RIGHT NOW?

Before you consider Medtronic Plc, you'll want to hear this.

The Motley Fool Stock Advisor analyst team just revealed what they believe are
the 10 best stocks for investors to buy right now... and Medtronic Plc wasn't
one of them.

Stock Advisor is the online investing service that has beaten the stock market
by 3x since 2002*. And right now, they think there are 10 stocks that are better
buys.

See the 10 stocks



*Stock Advisor returns as of April 24, 2023





Adria Cimino has no position in any of the stocks mentioned. The Motley Fool has
positions in and recommends Nvidia. The Motley Fool recommends Johnson &
Johnson. The Motley Fool has a disclosure policy.

5 Stocks Under $49

We hear it over and over from investors, “I wish I had bought Amazon or Netflix
when they were first recommended by the Motley Fool. I’d be sitting on a gold
mine!” And it’s true.

And while Amazon and Netflix have had a good run, we think these 5 other stocks
are screaming buys. And you can buy them now for less than $49 a share!

You can grab a copy of “5 Growth Stocks Under $49” for FREE for a limited time
only.

Click here to learn more.

Learn more


INVEST SMARTER WITH THE MOTLEY FOOL


JOIN OUR PREMIUM MEMBERS RECEIVING…

 * New Stock Picks Each Month
 * Detailed Analysis of Companies
 * Model Portfolios
 * Live Streaming During Market Hours
 * And Much More

Get Started Now


STOCKS MENTIONED

Medtronic Plc
MDT
$89.69 (%)


MOTLEY FOOL STOCK ADVISOR'S LATEST PICK

Get Access
395% Avg Return*
Nvidia
NVDA
$262.41 (-2.96%) $-8.01

*Average returns of all recommendations since inception. Cost basis and return
based on previous market day close.


RELATED ARTICLES

Why Medtronic Stock Edged Higher Today
Why Medtronic Stock Soared More Than 4% Higher Today
If You Invested $10,000 in Medtronic in 2013, This Is How Much You Would Have
Today
2 Top Healthcare Stocks to Buy Right Now
2 Dividend Growth Stalwarts With Impressive Streaks Going and Yield Twice That
of the S&P 500
395%


MOTLEY FOOL RETURNS

Market-beating stocks from our flagship service.

Stock Advisor Returns
395%
 
S&P 500 Returns
118%

Calculated by average return of all stock recommendations since inception of the
Stock Advisor service in February of 2002. Returns as of 04/26/2023.

Discounted offers are only available to new members. Stock Advisor list price is
$199 per year.

Join Stock Advisor
Cumulative Growth of a $10,000 Investment in Stock Advisor

Calculated by Time-Weighted Return since 2002. Volatility profiles based on
trailing-three-year calculations of the standard deviation of service investment
returns.




OUR MOST POPULAR ARTICLES

3 No-Brainer Stocks to Buy With $300 Right Now

For Only the 4th Time in 63 Years, This Economic Indicator Offers an Ominous
Warning for Wall Street

The Fed Says a Recession Is Coming: History Says the Stock Market Will Do This
Next

3 Unstoppable Stocks That Can Safely Turn $325,000 Into $1 Million by 2033


PREMIUM INVESTING SERVICES

Invest better with The Motley Fool. Get stock recommendations, portfolio
guidance, and more from The Motley Fool's premium services.

View Premium Services

Making the world smarter, happier, and richer.

 * Facebook Facebook
 * Twitter Twitter
 * Linked In LinkedIn
 * Pinterest Pinterest
 * YouTube YouTube
 * Instagram Instagram
 * Tiktok TikTok

© 1995 - 2023 The Motley Fool. All rights reserved.


Market data powered by Xignite.


ABOUT THE MOTLEY FOOL

 * About Us
 * Careers
 * Research
 * Newsroom
 * Contact
 * Advertise


OUR SERVICES

 * Stock Advisor
 * Rule Breakers
 * Rule Your Retirement
 * The Ascent
 * All Services


AROUND THE GLOBE

 * Fool UK
 * Fool Australia
 * Fool Canada


FREE TOOLS

 * CAPS Stock Ratings
 * Discussion Boards
 * Calculators
 * Financial Dictionary


OUR AFFILIATES

 * Motley Fool Asset Management
 * Motley Fool Wealth Management
 * Motley Fool Ventures
 * Lakehouse Capital
 * 1623 Capital

 * Terms of Use
 * Privacy Policy
 * Disclosure Policy
 * Accessibility Policy
 * Copyright, Trademark and Patent Information
 * Terms and Conditions
 * Do Not Sell My Personal Information

Current


This website uses cookies to deliver our services and to analyze traffic. We
also share information about your use of our site with advertising and other
partners. Privacy Policy

Got it
Cookie Settings